Joseph Edelman – CNTA history
- Issuer:
- CENTESSA PHARMACEUTICALS PLC
- Quarters tracked:
- 10 (Q1 2024 → Q2 2026)
- Current shares:
- 0
- Current value:
- $0
- Peak shares:
- 6,349,220 (Q4 2024)
- Overall change:
- -100%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q2 2026 | SOLD | — | — | -5,258,903 | -100% |
| Q1 2026 | 5,258,903 | $208.88M | $39.72 | +2,341,269 | +80% |
| Q4 2025 | 2,917,634 | $72.97M | $25.01 | -183,268 | -6% |
| Q3 2025 | 3,100,902 | $75.20M | $24.25 | +1,953,967 | +170% |
| Q2 2025 | 1,146,935 | $15.07M | $13.14 | -1,893,460 | -62% |
| Q1 2025 | 3,040,395 | $43.72M | $14.38 | -3,308,825 | -52% |
| Q4 2024 | 6,349,220 | $106.35M | $16.75 | +66,930 | +1% |
| Q3 2024 | 6,282,290 | $100.45M | $15.99 | +2,348,983 | +60% |
| Q2 2024 | 3,933,307 | $35.52M | $9.03 | +850,000 | +28% |
| Q1 2024 | 3,083,307 | $34.84M | $11.30 | — | NEW |